ININFA   02677
INSTITUTO DE INVESTIGACIONES FARMACOLOGICAS
Unidad Ejecutora - UE
artículos
Título:
Signal transduction mechanism of biased ligands at histamine H2 receptors.
Autor/es:
ALONSO NATALIA; MONCZOR FEDERICO; ECHEVERRIA EMILIANA; DAVIO CARLOS; SHAYO CARINA; FERNADEZ NATALIA
Revista:
BIOCHEMICAL JOURNAL
Editorial:
PORTLAND PRESS LTD
Referencias:
Lugar: Londres; Año: 2014 vol. 459 p. 117 - 126
ISSN:
0264-6021
Resumen:
7TMR exists as conformational
collections where different conformations would
lead to differential downstream behaviors as
receptor phosphorylation, G-protein activation
and receptor internalization between others. In
this context, a ligand may cause differential
activation of some but not all of the signaling
events associated to a particular receptor
leading to biased agonism. Knowing the
importance for research and pharmacological
uses of proper ligand classification into agonists,
inverse agonists, and antagonists, the aim of the
present work was to study the possibility that
histamine H2 receptor (H2R) ligands described
as inverse agonists due to their negative efficacy
at modulating adenylyl cyclase could display
some positive efficacy concerning receptor
desensitization, internalization or even signaling
through an adenylyl cyclase independent
pathway. Our present findings indicate that
treatment with H2R inverse agonists leads to
receptor internalization in HEK293T
transfected cells, by a mechanism mediated by
arrestin and dynamin but independent of
GRK2-mediated phosphorylation. On the other
hand we demonstrated that two of the H2R
inverse agonists tested, ranitidine and tiotidine,
induce also receptor desensitization. Finally, we
showed that these ligands are able to display
positive efficacy towards ERK1/2 pathway by a
mechanism that involves Gβγ and PI3K
mediated signaling in both HEK293T
transfected cells and in human gastric
adenocarcinoma cells. These results point to the
pluridimensional aspect of the efficacy of H2R
as a phenomenon that could be extended to
naïve cells, and challenge previous classification
of pharmacologically relevant histaminergic
ligands.